Nucleic Acid Detection and Quantification
The electronic detection of nucleic acids using TMSD on a gFET chip addresses the limitations of current methods by providing rapid, sensitive, and specific diagnostics suitable for remote environments, achieving high sensitivity and reducing equipment needs.
Patent Information
- Application Number
- JP2024533095
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-12-01
- Filing Date
- 2022-12-01
- Publication Date
- 2024-11-08
AI Technical Summary
Current nucleic acid detection methods require lengthy sample purification, specialized equipment, trained personnel, and are not suitable for remote environments with limited resources, failing to meet the ASSURED criteria for rapid, sensitive, and specific diagnostics.
An electronic detection method using toehold-mediated strand displacement (TMSD) reactions on a graphene field effect transistor (gFET) chip, enabling label-free, enzyme-free, and isothermal detection of single-stranded nucleic acids without amplification, allowing miniaturization and portability.
The method achieves high sensitivity and specificity at low concentrations, reducing the need for complex equipment and enabling rapid, cost-effective detection and quantification of nucleic acids, suitable for diverse applications including medical diagnostics and environmental monitoring.
Smart Images

Figure 2024541674000004 
Figure 2024541674000005 
Figure 2024541674000006
Abstract
Description
[Technical field]
[0001] The present invention relates to a process for electronically detecting single-stranded nucleic acids and to a biosensor that may be used in such a process. The present invention also relates to the use of the process and the biosensor for detecting one or more single-stranded nucleic acids. [Background technology]
[0002] Identification of specific nucleic acid sequences is an important tool in species identification as well as in monitoring chemical markers for health and disease. Species identification is useful for a variety of applications, such as medical diagnostics to identify pathogenic organisms, as well as monitoring different pathogen strains, food safety monitoring or environmental surveillance. Nucleic acids act as messengers or indicators of health and disease. For example, mRNA (messenger RNA) or miRNA (microRNA) can also be used for diagnostic and monitoring purposes. Numerous nucleic acid detection methods, such as PCR (polymerase chain reaction), real-time PCR, isothermal amplification, and even gene sequencing, are now standard diagnostic methods. Many of these methods are very sensitive and versatile bioanalytical techniques, but are also cumbersome due to long sample purification or assay procedures, the need for additional equipment, the need for highly trained personnel, and the overall long time from sample collection to obtaining results. If a diagnostic method is to be deployed to a large population, an acceptable cost must be in line with the principles of the ASSURED criteria (available, sensitive, specific, easy to use, fast and reliable, no equipment required, and deliverable to end users) from the World Health Organization Bulletin on the selection of diagnostic tests. In this light, the deployment of diagnostic methods with high sensitivity and specificity that can be performed without external power at room temperature in resource-limited and remote settings is highly desirable. Toehold-Mediated Strand Displacement Reactions (TMSD) as a biological detection mechanism pathway are of particular interest in addressing at least some or a combination of the ASSURED criteria. In TMSD, nucleic acid strands, such as ribonucleic acid (RNA) or deoxyribonucleic acid (DNA), spontaneously anneal to form duplexes based on complementary Watson-Crick base pairs. Base pair displacement is driven by the net gain of free energy from base pairing rather than single strandedness. Thus, a single-stranded invading strand can purposefully displace another strand that is already annealed to its complementary strand in a double-stranded sequence. This exchange occurs within a matter of seconds to minutes and requires a free, single-stranded, complementary "toehold" domain in the nucleotide duplex. The toehold can initiate displacement as short as one nucleotide (nt). These displacements occur in solution over a wide temperature range. In the field of dynamic nucleic acid nanotechnology, this principle has led to the creation of complex cascade mechanisms, including logic operations and the design of enzyme-free catalytic systems. The displacement reaction can be fine-tuned to the intended operating temperature by selecting the appropriate length and base pair composition, or by choosing to introduce nucleic acid analogs not found in natural DNA or RNA but subject to the same Watson-Crick base pairing mechanism. For example, TMSDs have been adapted to perform nano-sized molecular machine tasks, including detection mechanisms for diagnostic purposes: strand displacement has been demonstrated, for example, for the detection of tuberculosis pathogen mRNA markers by a fluorescent dye-quencher reporter mechanism. Traditionally, detection of specific sequences of DNA and RNA has long relied on polymerase chain reaction (PCR). Primers are used to target a specific sequence of DNA or RNA, which, if present, is further amplified with the help of a polymerase enzyme until the amount of nucleic acid is sufficient for detection. Detection methods for PCR products (amplicons) usually involve a combination of size separation gels with intercalating fluorescent dyes, direct detection as the amplicons emerge in real time, or targeted fluorescent probes. PCR reactions often require temperature cycling and precise, rapid temperature changes in the range of 50-100°C. This requires sophisticated, cumbersome, and often expensive equipment. Isothermal amplification methods are less demanding in terms of equipment, but require sophisticated sequence design and the presence of enzymes to perform the amplification, and have limitations on storage temperatures and expiration dates for reagents. Similarly, the fluorescent dyes required for effective amplification detection require storage protected from light and heat, and often require sophisticated equipment to achieve detection at low concentration levels. All currently available techniques for the analysis of nucleic acid markers require specialized equipment, space and infrastructure, various reagents with specific storage conditions, highly trained personnel, and long test times. Most nucleic acid amplification techniques are enzyme-mediated and require the use of primers, which, given their sensitivity to heat, light, and oxidation, require careful storage and handling of the enzymes and primers, other reagents, and the sample itself. Current equipment used to analyze nucleic acids is often large and requires dedicated space. As a result, samples must be transported to the analysis facility, further increasing the time required for results. Amplification of a nucleic acid marker of interest first requires the use of primers to identify the marker among other nucleic acids present in the sample. Any errors made at this stage will lead to amplification of the errors in subsequent amplification steps, resulting in erroneous results being reported. Other typical shortcomings of current techniques include false positive results, reliance on the use of primers and enzymes, and limited available process optimization. There remains a need for efficient, sensitive and economical processes and devices that allow for rapid and efficient detection and / or quantification of nucleic acids present in biological samples. Summary of the Invention
[0003] The present invention relates to a process and device useful for detecting and / or quantifying nucleic acid sequences.Current processes used for detecting nucleic acids are usually enzyme-based, require a separate amplification step, and use direct detection techniques, i.e., techniques that detect the nucleic acid of interest.In contrast, the process disclosed herein relies on electronic detection of displaced moieties mediated by binding to nucleic acid.Since binding to a single unit of nucleic acid results in the displacement of multiple moieties, which are then electronically detected, no separate amplification step is required. In the context of the present invention, we disclose electronic detection of single-stranded nucleotide sequences of interest mediated by a series of strand displacement reactions resulting in the release of multiple shorter charged oligonucleotides (see, for example, FIG. 1). These signal nucleotides can be detected electronically by transducing an electrochemical signal on a gFET (graphene field effect transistor) chip surface rather than by colorimetric or fluorescent / luminescent readout. Detection can be performed at room temperature, except when used downstream in other assays such as PCR, which employ varying temperatures. The method can be performed label-free, enzyme-free, and isothermal at room temperature conditions with electronic readout. The miniaturization of the chip geometry, combined with microfluidics, allows signal detection to be configured for multiple targets. This combination of advantages means that devices incorporating the proposed TMSD mechanism can be miniaturized and portable, addressing several of the ASSURED criteria. Many of the previously reported detection methods rely on the readout of optical signals, such as the fluorescent signal of nucleotides, rather than the electronic readout that is the subject of the present invention. For example, some techniques have been reported that combine readout methods that detect changes in fluorescent signals and fluorescence polarization. In contrast, the present invention relies on electronic readout of binding events on the graphene chip surface. As used herein, the term "electronically readable" in the context of electronically readable nucleic acid sequences refers to nucleic acid sequences that are detected by converting an electrochemical signal on a gFET (graphene field effect transistor) chip surface, rather than using optical or spectroscopic readouts such as colorimetric, fluorescent or phosphorescent (luminescent) readouts. Thus, the present invention should be contrasted with similar technologies that utilize optical or spectroscopic readout methods. Thus, the present invention relates to embodiments of electronically readable single-stranded nucleic acid sequences, which are sequences that do not require detection of changes in fluorescent signals and fluorescence polarization. Thus, the present invention also relates to embodiments of electronically readable single-stranded nucleic acid sequences that do not require detection of colorimetric changes. Since nucleic acid sequences exhibit specific binding to complementary sequences, the binding-displacement process disclosed herein can be adapted to detect specific sequences by using a complementary sequence that is complementary to the nucleic acid sequence of interest. The process disclosed herein relies on the use of a nucleic acid sequence in electronic communication with a graphene surface, which sequence is complementary to the sequence of interest. This sequence hybridizes with an oligonucleotide, which is then displaced and detected if present. This displacement of the oligonucleotide is mediated by the binding of the nucleic acid of interest via a toehold strand displacement mechanism. A toehold region in this context is a free single-stranded domain in place that can bind to an incoming complementary sequence. In the process disclosed herein, the incoming sequence includes the nucleic acid sequence of interest, but the toehold region is a portion of the sequence that can be attached to a surface. Binding of the incoming nucleic acid sequence to the toehold region results in further hybridization of the incoming nucleic acid and simultaneous displacement of the bound oligonucleotide, which is then electronically detected. Binding to one nucleic acid can result in the displacement of multiple oligonucleotides (see, for example, FIG. 5), with the detected signal appearing amplified relative to the incoming nucleic acid. In FIG. 1, the displaced nucleic acid initiates another series of stepping-stone mediated displacements. The nucleic acids displaced in this reaction are then electronically detected. The present disclosure also relates to a process whereby a nucleic acid sequence comprising an initial toehold region can be immobilized on a surface, in particular a graphene surface, where a change in charge on the graphene surface can be converted into a change in electrical current, which can then be detected by suitable means. Thus, according to a first aspect, the present invention provides a method for producing a method for treating a cancer cell comprising: 1. A method for producing one or more electronically readable single stranded nucleic acid sequences, comprising: 1) i) a partially double-stranded detection gate nucleic acid construct (DG), a. A single-stranded detector substrate nucleic acid sequence (DSSS) having a partial region complementary to a partial region of a reporter nucleic acid sequence (RSS) and a stepping-stone sequence (THS) region that is non-complementary to the RSS but partially complementary to a partial sequence of a single-stranded invader nucleic acid sequence (ISS); b. a single-stranded RSS having a region complementary to a portion of the DSSS and a region complementary to one or more electronically readable regions of the signal substrate strand (SSS) but not complementary to the RSS, the DSSS, or the ISS; A partially double-stranded detection gate nucleic acid construct (DG) comprising: ii) a single-stranded invader nucleic acid sequence (ISS) having a region complementary to the THS of the DSSS; iii) a partially double-stranded signal gate construct (SG), a. an SSS that is the complement of the RSS and also contains a toehold sequence (THS) that is complementary to the RSS; b. a plurality of electronically readable signal oligonucleotides (SO) that are complementary to a portion of the SSS but are not the THS of the SSS; A partial double-stranded signal gate construct (SG) comprising selecting 2) reacting the DG with the ISS in a manner and under conditions such that the THS region on the DG initiates binding of the ISS, resulting in displacement of the RSS, which further binds to the THS of the SG, releasing the one or more electronically readable single-stranded SO sequences; The method further comprises: According to a second aspect, the present invention provides a method for producing a composition comprising the steps of: 1. A method for producing one or more electronically readable single stranded nucleic acid sequences, comprising: 1) selecting a partially double-stranded detection gate nucleic acid sequence (DG) comprising a detection substrate strand (DS) and one or more signal oligonucleotide (SO) strands comprising a pre-electronically readable sequence, wherein the DS and SO have partial complementarity, and the DG also has a stepping-stone sequence region (THS) and a single-stranded invader nucleic acid sequence (ISS) having a region complementary to the THS and SO regions; 2) reacting the DG with the ISS in such a manner and under such conditions that the THS region on the DG initiates binding with the ISS and displaces one or more electronically readable single-stranded SO from the pre-electronically readable region, where the one or more electronically readable single-stranded nucleic acid sequences are the same or different; The method further comprises: In certain embodiments, with reference to both aspects, electronically readable single-stranded nucleic acid sequences are readable on the gFET graphene surface. The methods disclosed herein and devices incorporating the methods relate to the detection of nucleic acid sequences of interest by displacement and subsequent detection of one or more electronically readable single-stranded nucleic acid sequences. This displacement mechanism is advantageous due to the increase in entropy resulting from the release of bound sequences and the stable double-stranded sequences resulting from hybridization of complementary nucleic acid strands. In embodiments of the first and second aspects, the single-stranded invader nucleic acid sequence is single-stranded RNA or single-stranded DNA. In some embodiments, the single-stranded invader nucleic acid is messenger RNA (mRNA) or microRNA (miRNA). In some embodiments of the first and second aspects, the single-stranded invader nucleic acid sequence may be a natural nucleic acid sequence.The invader nucleic acid sequence is named as such because it is of viral, bacterial, human or microbial origin based on the disease to be detected.For example, the specific mRNA can be a cancer diagnostic marker, and can also be related to other non-communicable diseases. In another embodiment of the first and second aspects, the single stranded invader nucleic acid sequence is a bridge nucleic acid or a peptide nucleic acid. In another embodiment of the first and second aspects, the single stranded invader nucleic acid sequence comprises one or more inosine nucleosides. In another embodiment of the first and second aspects, the single stranded invader nucleic acid sequence is in the form of an aptamer. In another embodiment of the first and second aspect, the DG and / or SG and / or components of the single stranded invader nucleic acid sequence are non-naturally occurring nucleic acid sequences. In another embodiment of the first and second aspects, the displacement of the electronically readable single stranded nucleic acid sequence is the result of toehold strand displacement mediated by a single stranded invader nucleic acid sequence. In some embodiments, the single-stranded detector substrate nucleic acid sequence is an oligonucleotide. In another embodiment of the first and second aspects, the method comprises the further step of analysing single stranded nucleic acid of a PCR reaction or other polymerase-mediated reaction, such as sequencing by synthesis. The inventors have discovered that the methods and devices disclosed herein rely on the generation of a surface charge difference that is detected as a result of the displacement of an electronically readable single stranded nucleic acid sequence. This change in surface charge is detected by an appropriate sensor. In some embodiments, the electronically readable single-stranded nucleic acid sequence is modified to include an additional charged group. In some embodiments, the charged group may be a phosphate group. In another embodiment, the sequence may include biotin or streptavidin or analogs thereof. In another embodiment of the first and second aspects, the displaced electronically readable single stranded nucleic acid sequence is detected by a field effect transistor (FET). Because the processes and devices disclosed herein include graphene surfaces and, in certain embodiments, field effect transistors, the processes and devices are capable of much higher sensitivity in measurements. In contrast to detection by colorimetric or spectrophotometric means, the detection limits achievable by the processes and devices disclosed herein are much lower than currently achieved in the art. For example, current detection of nucleic acids requires attomoles (10-18 ) concentration. This is because the methods and devices disclosed herein can be modified such that binding to a single nucleic acid strand results in displacement and detection of multiple electronically readable single-stranded nucleic acid sequences. This is achieved by hybridizing the detector substrate nucleic acid sequence with multiple shorter electronically readable single-stranded nucleic acid sequences that are displaced as a result of initial binding of the single-stranded invader nucleic acid sequence at the toehold region of the single-stranded detector substrate nucleic acid sequence. In another embodiment of the first and second aspects, the single stranded Invader nucleic acid sequence is about 1x10 -6 M ~ approx. 1x10 -18 M. In some embodiments, the single-stranded invader nucleic acid replaces one single-stranded signal oligonucleotide sequence. This may be an indirect replacement mediated by a reporter sequence (first aspect) or a direct replacement (second aspect). In another embodiment, the single-stranded invader nucleic acid replaces multiple single-stranded signal oligonucleotide sequences. In another embodiment, the single-stranded invader nucleic acid sequence replaces 1 to 10 single-stranded signal oligonucleotide nucleic acid sequences, for example, 2, 3, 4, 5, 6, 7, 8, 9 or 10 single-stranded signal oligonucleotide nucleic acid sequences. The method described herein is not enzyme-based and does not require sensitive reagents, so the process is much more robust than those currently used in the field and can be used at room temperature. Furthermore, because the method does not require the use of enzymes, there is no need to maintain the pH of the test sample containing single-stranded nucleic acid and the pH of the test environment in a specific range of use. The inventors have found that the limitations on salt concentration, buffer concentration and operating temperature required for comparative methods such as polymerase chain reaction (PCR) are not required for the method disclosed herein. Compared to other processes known in the art that detect and quantify nucleic acids in a comparable manner, the method described herein allows for more rapid analysis. The methods disclosed herein may be incorporated into chips, such as silicon chips with suitable surface treatment. In certain embodiments, the methods disclosed herein may be incorporated into silicon chips that include one or more graphene layers. For example, the methods disclosed herein may be performed on a surface that contacts a nucleic acid sequence. The inventors have found that the use of a graphene surface with a suitable detector allows for detection of charge changes mediated by displacement of one or more electronically readable single-stranded nucleic acid sequences. Furthermore, the use of graphene avoids known chemical incompatibility with biological samples and reagents that contain nucleic acids, allowing for the production of lightweight and portable devices. In some embodiments, the graphene surfaces described herein comprise one or more graphene sheet layers, hi some embodiments, the graphene surfaces comprise multiple graphene sheet layers. In some embodiments, the graphene sheets are further modified: In some embodiments, the graphene sheets may be surface modified to include electronic configurations that give rise to positive or negative charges, such as phosphate groups, hydroxyl groups, carboxylate groups, carboranes, protons, or electrons. According to a third aspect, the present invention relates to a biosensor comprising a graphene surface, the surface being configured to detect a change in charge associated with a method defined in the first aspect. In a particular embodiment, the biosensor comprises one or more graphene layers. In certain embodiments, the biosensor comprises one or more nucleic acid sequences on the graphene surface via one or more linkers. The inventors have found that the biosensor device disclosed herein may be modified to include multiple nucleic acid sequences immobilized on the graphene surface. The biosensor may be used to simultaneously detect and / or quantify multiple single-stranded nucleic acids in a sample, where the different nucleic acid sequences are specific for different single-stranded nucleic acids. Without wishing to be bound by theory, the inventors believe that modifying the graphene surface of the biosensor to include a variety of different immobilized nucleic acid means enables a device capable of detecting multiple single-stranded nucleic acids of interest. This is in contrast to current technology, which generally only allows for the detection of a single nucleic acid in a single assay. In certain embodiments, the biosensor comprises a plurality of different nucleic acid sequences immobilized on a graphene surface, where each of the different nucleic acid sequences comprises a nucleic acid sequence that hybridizes to a different reporter oligonucleotide. According to a fourth aspect, the present invention relates to the use of a biosensor as defined in the second aspect for detecting and / or quantifying one or more electronically readable single-stranded nucleic acids. In certain embodiments of the fourth aspect, multiple single-stranded nucleic acids are detected and / or quantified simultaneously. [Brief description of the drawings]
[0004] [Figure 1] FIG. 1 is a schematic diagram for generating one or more electronically readable single-stranded nucleic acid sequences (eg, DNA or RNA) according to the methods described herein. [Figure 2A] FIG. 1 shows the individual components resulting from the method described herein. The components resulting from the strand displacement mechanism described herein are separated and visualized by gel electrophoresis. A 100 ms exposure of the gel is shown. [Figure 2B] FIG. 1 shows the individual components resulting from the method described herein. The components resulting from the strand displacement mechanism described herein are separated and visualized by gel electrophoresis. A 4000 ms exposure of the gel is shown. [Diagram 3]FIG. 1 shows that the strand displacement reaction described herein produces stoichiometric amounts of electronically readable single-stranded nucleic acid sequences. [Figure 4] Graph showing signal intensity calculated from gel bands of signal oligonucleotides (shown in Fig. 3B2 and Fig. 3D) for negative reactions without INVADER (blue) and positive reactions with INVADER (orange). Asterisks indicate the significance of the applied t-test. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. [Diagram 5] FIG. 1 is a schematic diagram of detection of electronically readable single-stranded nucleic acid sequences without an intermediate reporter oligonucleotide. [Figure 6] FIG. 1 shows a multiplex detection system constructed with microfluidic channels coated with specific signal gate constructs for the detection of electronically readable single-stranded nucleic acid sequences. A multiplex detection system can be constructed with microfluidic channels coated with specific signal gate constructs. In a solution of multiple target sequences T and corresponding detection gates [R / D], T displaces the appropriate reporter sequence R from the detection gate. The released nucleotide strand R enters the microfluidic lane and contacts multiple signal gates [3X / S], but displaces only the signal nucleotide X that matches the substrate strand S. The released nucleotide emits a signal on the FET chip surface. [Figure 7] Structure of a bridged nucleic acid monomer and a DNA monomer. Bridged nucleic acids are nucleic acid analogs that contain a 2'-O, 4'-C methylene bridge. This bridge, locked in a 3'-endo conformation, restricts the flexibility of the ribofuranose ring and locks the structure into a rigid bicyclic form. [Figure 8] The structure of protein nucleic acids and DNA. In peptide nucleic acids, the phosphoribose backbone of DNA is replaced with a peptide backbone. This nucleic acid analog is resistant to nucleases and undergoes normal Watson-Crick base pairing with DNA or PNA, but has higher specificity and melting temperature than a DNA:DNA duplex. [Figure 9]Graphs showing detection of ions and DNA on a gFET. A: Different concentrations of NaCl solutions (orange arrows) were pipetted onto the graphene sensing area of a gFET with rinsing with water in between (light blue arrows). Measurements of 0.5M (orange arrows 1-4) and 0.01M NaCl (orange arrows 5-8) were performed in quadruplicate. B: Salmon sperm genomic DNA was diluted in water and transferred to the chip surface in the following order: 0.0001mg / ml, 0.01mg / ml, and 1mg / ml (indicated by orange arrows). The chip was rinsed with water between DNA additions (light blue arrows). C: The chip was then exposed to different concentrations of ssDNA in water in the following order: 1uM, 10uM, 1uM, and 100uM ssDNA (indicated by orange arrows). Between each new DNA concentration, the sensing surface was rinsed with water (light blue arrows). All measured current values for I_sd are plotted in blue, while the average of the last 20 values (equal to one oscillation cycle of V_sd) is shown in orange. BEST MODE FOR CARRYING OUT THEINVENTION
[0005] Throughout this specification and the appended claims, unless the context requires otherwise, the word "comprise", as well as variations such as "comprises" and "comprising", are understood to mean the inclusion of a stated integer or step or group of integers or steps, but not the inclusion of any other integer or step or group of integers or steps. The terms "about" or "approximately" are used herein to mean that a particular value, as determined by one of ordinary skill in the art, is within an acceptable error range, which will depend in part on how the value is measured or determined, i.e., the limitations of the measurement system. As used herein, the singular forms "a," "an," and "the" include plural embodiments unless the context clearly dictates otherwise. Thus, for example, reference to "a method" includes two or more methods as well as a single method, reference to "an agent" includes two or more agents as well as a single agent, and reference to "the disclosure" includes single or multiple embodiments taught by the disclosure, and so forth. The embodiments taught and enabled herein are included in the term "invention." Any variations and derivatives contemplated herein are included in "forms" of the invention. Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. For purposes of the present invention, the following terms are defined below. As used herein, the term "graphene" refers to an allotrope of carbon having a two-dimensional structure in which carbon atoms exist in a single layer. Multiple graphene layers (also known as "sheets") may be sequentially deposited on a surface to obtain multiple graphene layers with no interplanar correlation. As used herein, the term "graphene" is used to refer to both single-layer and multilayer configurations. As used herein, the terms "nucleic acid" and "nucleotide" refer to a moiety that includes a nitrogenous base (i.e., nucleobase) and a sugar moiety bound to a phosphate group. The nitrogenous base and sugar moiety together may be considered a "nucleoside." The nucleobase may be a purine or pyrimidine base, or other naturally occurring, chemically or biochemically modified, non-natural base or derivatized base. Examples of purine bases include adenine (A) and guanine (G), and examples of pyrimidine bases include cytosine (C), thymine (T), and uracil (U). The sugar of the nucleotide (or nucleoside) may be a ribose group or a deoxyribose group. Nucleic acids may be double-stranded or single-stranded. Reference to a single-stranded nucleic acid includes reference to the sense strand or the antisense strand. When a ribose group is present in a nucleotide, the nucleotide may be a component of ribonucleic acid (RNA). When a deoxyribose group is present in a nucleotide, the nucleotide may be a component of deoxyribonucleic acid (DNA). The nucleotides may be standard nucleotides or their analogs, naturally occurring or non-naturally occurring. The nucleotides may be analogs and contain one or more modifications compared to natural nucleotides. Examples of such modified nucleotides (i.e., nucleotide analogs) include methylated nucleotides and nucleotide analogs. The sequence of nucleotides may be interrupted with non-nucleotide moieties. Other modifications include modifications incorporated to protect the single-stranded domain from degradation by nucleases, such as 3'-phosphorylation. The nucleic acid may also be a peptide nucleic acid, which has a peptide chain instead of a phosphoribose backbone derived from sugar and phosphate groups, thus providing a nucleic acid that undergoes standard base pairing but is not recognized by nucleases, thereby making it less susceptible to degradation. The terms nucleoside, nucleotide, deoxynucleoside and deoxynucleotide generally include complementary strands, fragments and variants of nucleosides, nucleotides, deoxynucleosides and deoxynucleotides, or their analogs. As used herein, the term "nucleotide" also includes "polynucleotide," which refers to any suitable polynucleotide, including, but not limited to, cDNA, mitochondrial DNA (mtDNA), messenger RNA (mRNA), ribosomal RNA (rRNA), transfer RNA (tRNA), nuclear RNA (nRNA), small interfering RNA (siRNA), small nuclear RNA (snRNA), small nucleolar RNA (snoRNA), small Cajal body-specific RNA (scaRNA), microRNA (miRNA), double-stranded (dsRNA), ribozyme, riboswitch, or viral RNA. The polynucleotide may be contained within any suitable vector, such as a plasmid, cosmid, fragment, chromosome, or genome. The polynucleotide analyte may be a nucleic acid endogenous to a cell. As another example, the polynucleotide analyte may be a nucleic acid introduced or expressed into a cell by infection of the cell with a pathogen, such as, for example, viral or bacterial genomic RNA or DNA, plasmid, viral or bacterial mRNA. As used herein, the term "complementary" in relation to a nucleic acid sequence refers to a nucleic acid sequence that hybridizes to another nucleic acid sequence. As used herein, the term "hybridization" in relation to a nucleic acid sequence generally refers to the formation of a double-stranded nucleic acid construct from two single-stranded constructs, which are joined by base pairing according to the Watson-Crick principle. Nucleic acid sequences that hybridize in a complementary manner through nucleotides or nucleosides or their analogs. Complementary nucleotides are generally A and T (or A and U), or C and G. The term "hybridization" may also refer to triple-stranded hybridization. The resulting (usually) double-stranded polynucleotide is a "hybrid." The proportion of the polynucleotide population that forms stable hybrids is referred to herein as the "degree of hybridization." Two single-stranded RNA or DNA molecules are said to be complementary when the nucleotides of one strand are optimally aligned, compared, and pair with at least about 80% of the nucleotides of the other strand, usually at least about 90%-95%, more preferably about 98%-100% of the nucleotides of the other strand, with appropriate nucleotide insertions or deletions. Alternatively, complementarity exists when an RNA or DNA strand hybridizes under selective hybridization conditions to its complementary strand. Typically, selective hybridization occurs when there is at least about 65% complementarity, preferably at least about 75%, more preferably at least about 90% complementarity for a stretch of at least 14-25 nucleotides. As used herein, the term "oligonucleotide" refers to a sequence of nucleic acid bases that is less than about 200 nucleotides in length. Generally, oligonucleotides are about 15 to about 100 nucleotides in length, although oligonucleotides can be longer. Oligonucleotides can be DNA-based, RNA-based, or artificial analogs thereof. The term "immobilization" in relation to nucleic acid herein refers to the stable binding of said nucleic acid to a surface. The binding and subsequent immobilization of nucleic acid may be achieved by any mechanism, such as covalent, non-covalent, ionic, etc. When a single-stranded nucleic acid is immobilized on a surface, a further single-stranded nucleic acid having a complementary sequence may be bound to the immobilized nucleic acid by hybridization, thereby immobilizing a second nucleic acid construct. When a second single-stranded nucleic acid construct is bound to the immobilized nucleic acid by hybridization, the binding may be reversible, thereby separating the single-stranded nucleic acid previously hybridized to the immobilized nucleic acid. As used herein, the term "aptamer" refers to an oligonucleotide that binds to a specific target molecule. As used herein, the term "biosensor" refers to an analytical device that converts a biological reaction into a signal that can then be processed and quantified by appropriate means. As used herein, the term "sample" includes tissues, cells, body fluids and isolates thereof isolated from a subject, as well as tissues, cells, body fluids, etc. present within a subject (i.e., the sample is in vivo). Examples of samples include whole blood, blood (e.g., serum or plasma), lymph, cyst fluid, sputum, feces, tears, mucus, hair, skin, peritoneal fluid, cyst fluid, urine, nipple exudate, nipple aspirate, sections of tissue such as biopsy and autopsy samples, frozen sections taken for histological purposes, archival samples, explants and primary and / or transformed cell cultures derived from patient tissues, and the like. As used herein, the terms "detect", "determine", "measure", "verify", "assess" and "measure" are used interchangeably to refer to any form of measurement, including determining whether a particular element is present (or absent). These terms include both quantitative and / or qualitative measurements. Assessment may be relative or absolute. The processes defined herein may include measuring or visualizing the levels of two or more analytes in a sample. As used herein, the term "subject" or "patient" refers to any subject for whom treatment is desired, including humans, cows, horses, pigs, goats, sheep, dogs, cats, guinea pigs, rabbits, chickens, insects, plants, etc. Subjects are intended to include subjects involved in clinical research trials who do not show clinical signs of disease, or subjects involved in epidemiological studies, or control subjects. As used herein, the term "probe" refers to any molecule capable of selectively binding to a specifically intended target molecule, such as a nucleotide transcript. Probes can be synthesized by one skilled in the art or obtained from appropriate biological preparations. The term "graphene" refers to pure or relatively pure carbon in the form of a relatively thin, nearly transparent sheet, either one atom thick (i.e., a single sheet of carbon) or containing multiple layers with no interplanar correlation (multilayer carbon sheets), having multiple interconnected hexagonal cells of carbon atoms forming a honeycomb crystal lattice structure. In addition to hexagonal cells, pentagonal and heptagonal cells (defects) to the hexagonal cells may be present in the crystal lattice. Graphene may be in any form known in the art. For example, graphene may be in powder form and in the form of a single sheet or multiple sheets. The term "functionalized graphene" refers to the addition of -OH, -COOH, -NH 2 It may also refer to graphene that has incorporated various chemical functional groups such as In the present invention, signal detection is mediated by a series of stepping-stone-mediated strand displacement reactions that result in the release of multiple shorter charged oligonucleotides that can be detected as an electrochemical signal on the gFET chip surface. The presented data show an example of a displacement mechanism that exhibits 1:3 interlocking, i.e., one reporter oligonucleotide releases three signaling charged nucleotides. This indicates successful assembly of the expected double-stranded and single-stranded products in a reaction initiated by an invader strand (Figure 2). The amount of released signal oligonucleotide increases as expected with the use of a signal gate loaded with more signal oligonucleotides (see Figure 3). However, higher interlocking can be achieved by derivatization. The direction of the displacement reaction is favored by the increased entropy due to the release of shorter charged oligonucleotides and the favorable binding of consecutive complementary strands. The system functions at room temperature and is therefore not dependent on an external power source or a cold logistics supply chain. Compared to protein-based enzyme-dependent signal amplification systems, the mechanism demonstrated by the present invention can also be more flexible to environmental conditions, including the operating pH range, salt concentration and temperature. Another advantage of the present invention is the increased sensitivity compared to direct detection approaches that rely on chemically binding molecules to the surface of the sensing device (e.g., chemical binding to electronically gated field effect transistors). During direct detection, the molecule of interest binds to the appropriate complementary sequence or antibody on the chip surface and is detected in situ. This approach has been shown to be very sensitive, even for low concentrations of disease markers, especially up to z molar concentrations when combined with gFET chips. In contrast, the present invention can successfully detect targets that release multiple shorter molecules. Thus, the advantage of label-free, enzyme-free direct detection is further boosted by the respective increased signal amplification. Exemplary data for an uncoated gFET detecting charged molecules in the form of salt ions (NaCl) and DNA (gDNA and ssDNA) is shown in Figure 9. PCR-based nucleic acid detection relies on enzymatic signal amplification. Because this amplification is exponential, these methods are highly sensitive. Although exponential amplification allows the detection of nucleic acid biomarkers at very low concentrations and to a lesser extent proteins (e.g. immuno-PCR), exponential amplification methods are also prone to contamination issues, false positives, and situations where multiple competing amplicons in the reaction mixture bias some sequences over others (e.g. more easily amplified sequences with different AT content, highlighting the challenges of PCR methods). Because the method relies on nucleic acids, it is more adaptable to different temperatures and less sensitive to buffers and analyte concentrations than protein-based detection methods. In this example, the sequence of interest displaces a reporter sequence on a DNA construct. The released reporter strand contains a sequence complementary to the foothold of the target double-stranded signal construct. The signal construct is composed of a substrate strand and multiple shorter complementary signal charged nucleotides that can be detected electronically, for example, by a gFET device. In this way, every sequence detected generates three molecules for detection by the chip surface. Although we have demonstrated a 1:3 input:output ratio (Figures 3 and 4), it is also possible to design larger amplifications, for example 1:5, by increasing the number of complementary domains and signal oligonucleotides. Amplification can be increased and optimized by sequence design, but may ultimately be limited by steric hindrance and the increased time scale to complete the displacement. In an alternative version of the method, it is possible to omit the reporter strand step and instead hybridize multiple shorter signal oligonucleotides to the detection substrate strand. In this design, the double-stranded detection construct first contains a domain that confers specificity to the target sequence, followed by a series of labeled shorter oligonucleotides that are displaced by the invader strand (see Figure 5) and detected by the chip. This potentially makes the overall reaction faster, but it needs to be optimized for each new target. The detection substrate strand needs to be redesigned for each new target, but so do the signal oligonucleotides. The nucleic acids used in this method may be RNA, DNA or synthetic nucleic acid analogs. The nucleic acid or analog constructs used in this mechanism may contain modifications to suit the intended purpose. Bridged nucleic acids (LNA) contain an oxygen bridge across the ribose backbone to better ensure high specificity of Watson-Crick pairing (see Figure 7). It has been shown that the incorporation of LNA segments into normal DNA can provide higher selectivity for certain genetic variants, e.g., single nucleotide polymorphisms (SNPs) indicative of disease. Other modifications, e.g., 3' phosphorylation, may be incorporated to protect the single-stranded domain from degradation by nucleases. Peptide nucleic acids (PNAs) are nucleic acid analogs with a peptide-linked chain instead of a phosphoribose backbone (Figure 8). PNAs are not recognized by nucleases and therefore are less susceptible to degradation, but like DNA or RNA, they form Watson-Crick base pairs, albeit with a high melting point, and therefore exhibit higher specificity compared to a comparable set of double-stranded DNA. This resilience and higher specificity have also made peptide nucleic acids a popular tool in biosensor research. According to the method of the invention, some strands are designed to be modified to selectively decrease or increase specificity, for example, to detect multiple similar variants that differ by several point mutations in the target region, the substrate of the detection complex may contain a position with the so-called universal base inosine (as this nucleoside can pair with G, C, A or T). To design shorter signal oligonucleotide fragments to include more signal molecules in the signal gate without increasing the length of the signal substrate or reporter strands, it would be desirable to obtain a higher melting temperature or a larger Gibbs free energy of base pairing. The sequence of interest detected by the present invention may be a single-stranded sequence of viral, bacterial or other microbial origin, or any other sequence of interest present in a given sample.To improve the detection speed and sensitivity of PCR-based assays, the sequence of interest may be used to detect nascent PCR products.Therefore, the number of PCR cycles required for successful detection of target material can be reduced. When the present invention is used in conjunction with a PCR system, the higher temperatures used in such environments may require adjustments to the signal nucleotide sequence and other modifications to increase the stability of the double-stranded detection and signal gate at higher temperatures in the absence of strand displacement events. The present invention can also be used to detect proteins or other antigens by using nucleic acid sequences in the form of aptamers, where the protein of interest displaces a nucleic acid reporter sequence bound to the aptamer by base pairing interactions, and the released binding partner can initiate a cascade as proposed for nucleic acid detection. Microfluidics (Figure 6) or barcode sequences or a combination of both can be used to allow the simultaneous detection of multiple targets from the same sample. The detection gate sequence can be designed to anneal with a specific target sequence, while the reporter strand is similarly different for each target. The determination of the presence of a specific target can be made in a microfluidics channel coated with a signal gate specific for the reporter. Any signal nucleotides generated by this displacement can be recorded by a device connected only to this channel, for example an FET. The miniaturization and low reaction volume allow the simultaneous detection of multiple targets for multiplexing applications. Any reference in this specification to a prior publication (or information derived therefrom) or to any public knowledge is not, and should not be taken as, an acknowledgement, acknowledgment or any suggestion that the prior publication (or information derived therefrom) or public knowledge forms part of the common general knowledge in the field of endeavor to which this specification pertains. Those skilled in the art will understand that the invention described herein is capable of variations and modifications other than those specifically described. The invention should be understood to include all such variations and modifications within its spirit and scope. The invention also includes all steps, features, compositions and compounds mentioned or shown in this specification, individually or collectively, in any and all combinations of any two or more of said steps or features. EXAMPLES
[0006] The following examples are illustrative of the present disclosure and should not be construed as limiting in any way the general nature of the disclosure throughout the specification. method Annealing of DNA probes in a thermocycler The double-stranded constructs were previously prepared in a thermocycler (Bio-Rad) in TAE buffer with magnesium (Sigma-Aldrich). The single-stranded components were combined to give a final product concentration of 4 uM, heated to 65°C, and cooled to 20°C at a controlled rate of 1°C / min. Strand exchange reaction In the strand-exchange reaction solution for the invader strand, a detection gate (DG) and a signal gate (SG) with corresponding nucleotide sequences were combined at equimolar concentrations, incubated, and the reaction products were separated on a gel. In the strand-exchange process, a construct that releases one signal nucleotide was compared with a construct that releases two or three signal nucleotides. The displacement reaction consisted of equal volumes (eg, 10 ul) of signal gate and detection gate, each of which was initiated by adding an invader chain at a concentration of 4 uM (final concentration 1.33 uM). Negative controls contained the same volume of 1x TAE / Mg buffer instead of Invader. The displacement reactions were incubated at room temperature for 40 min, then mixed with loading buffer and subjected to PAGE in 20% TBE at 200 V for 1 h. To calculate the relative concentration of signal nucleotide released upon strand exchange, a series of increasing concentrations (0, 0.5, 1, 1.5, 2, 2.0, 2.5, and 3-fold relative concentrations) of signal oligonucleotide alone were included in the reaction samples on the gel to establish a standard curve of signal nucleotide brightness. Polyacrylamide gel electrophoresis (PAGE) 12 pmoles of sample were loaded per lane onto a 20% TBE gel (Invitrogen), run at 200V for 1 hour, stained with SYBR Green II (Invitrogen) at 1:10,000 in TBE buffer (Invitrogen) for 10 minutes, and imaged on an iBright 1500 gel imager (Invitrogen) with exposure times of 100ms, 2000ms, and 4000ms. Quantification of bands by densitometry Uncompressed tiff images acquired for 2000 ms on an iBright imager were analyzed with the gel analysis plugin of ImageJ. A rectangular region encompassing the band of interest and the areas above and below it was selected on the gel image and moved horizontally only to select and compare signals between different lanes. A plot of pixel intensity of the rectangular region is then generated using ImageJ. Manually select the peak signal of the band. Partition the area under the curve and thus subtract the background and select the peak area. The area value of each peak is used in Excel for further analysis. The slope of the standard curve was calculated for the concentration series of the signal oligonucleotide band. The concentration of the signal nucleotide band generated by the exchange reaction was calculated by dividing the signal value of the strand displacement reaction by the slope of the standard curve. Values are plotted as box plots. Results from multiple assays were combined and compared for statistical significance using t-tests. Testing gFET response to DNA A series of DNA water dilutions was used to test the gFET response to increasing concentrations of genomic salmon (Sigma) or short oligonucleotide DNA (IDT). A gFET chip (Graphenea) was used to measure the current change over time (I_sd) at constant source-drain and gate voltages (V_sd=0.1V, V_g=0.2V). These changes were recorded and plotted as current versus time. Example 1 - Preparation of Graphene Graphene is grown using chemical vapor deposition (CVD). This typically involves decomposing hydrocarbons (typically alkanes or alcohols) from the gas phase in a heated chamber and growing graphene sheets on metal catalyst substrates. The graphene sheets then need to be transferred from these metal substrates to other silicon substrates. These substrates typically have a 300 nm thick layer of silicon dioxide on the silicon. This separates the conductive silicon from the graphene layer. A voltage is then applied to the silicon layer to achieve a back-gated graphene field effect transistor (gFET). Previously, polymethylmethacrylate (PMMA) was deposited on top of the graphene as a sacrificial layer. A metal etchant is then used to separate the graphene from the metal substrate, and the PMMA-coated graphene floats to the surface. To fabricate the gFET, a two-step lithography process is used to pattern the graphene and contact electrodes, which involves spin-coating a polymer resist and heat-treating it, followed by patterning using a UV or electron source. Example 2 - Synthesis of chain sequences and domains Table 1 - Nucleic acid sequences of all single-stranded components used in the experiments in Figures 2 and 3 are shown as a whole and divided into domain components. Domain labels a-d and a'-d' correspond to the example in Figure 1. The domain labels and their primary counterparts are complementary to each other, e.g., a' is the reverse complement of a, etc. Domain d and d1, d2, d3 all have the same sequence. Short domains e and e' on the reporter strand and d and d' on the signal substrate strand between them, respectively, are optionally added to leave space for the 5' label on the signal nucleotide and prevent annealing by steric hindrance. TIFF2024541674000001.tif237170TIFF2024541674000002.tif237170Example 3 - Preparation of double-stranded oligonucleotide probes Double-stranded probes were prepared using 40 mM Tris base, 20 mM acetic acid, 1 mM EDTA, 11.5 mM Mg(CH 3 COO) 2 The mixture was mixed at equimolar concentrations in a buffer solution containing 100% ethanol, heated to 65°C for 5 minutes, and cooled to 20°C at a cooling rate of 1°C per minute. Example 4 - Reaction conditions for strand displacement reaction Oligonucleotide strand displacement reactions were performed in 40 mM Tris base, 20 mM acetic acid, 1 mM EDTA, 11.5 mM Mg(CH 3 COO) 2 The oligonucleotides were mixed in equimolar concentrations ranging from 1 nM to 10 mM. Products from the strand displacement reaction were analyzed on 20% TBE-PAGE gels in TBE running buffer (Invitrogen) and incubated with SYBR Green (Invitrogen) at a 1:10,000 dilution in TBE buffer for at least 15 min. Gel images were captured on an iBright 1500 FL imager (Invitrogen). Example 5 - Detection of single-stranded nucleic acids (RNA or DNA) As shown in FIG. 1, the detection gate, which is a partially double-stranded construct of a reporter (1) and a substrate strand (2), contains domains a'+b' that are complementary to a conserved motif in the invader strand (3), which is the nucleotide sequence of interest. a' is a toehold sequence that initiates binding and displacement. Sequence a of the invader strand binds to the a' complement in the detection substrate strand (2). If an additional base matches b', the invader strand (3) displaces the reporter strand (1). The newly released reporter strand (1) anneals to the toehold of a partially double-stranded signal construct consisting of a signal substrate strand (4) and multiple signal oligonucleotides (5). A short signal oligonucleotide with an appropriate charge, i.e., a label (d 1 , d 2 , d 3 etc.) are detected by the instrument. Single-stranded components are labeled with a box number, and double-stranded constructs are labeled with a combination of the corresponding box numbers that are underlined. In this example shown, three signal molecules are released for each invader strand that is detected, so the labeling reflects this by showing 3x(5) signal molecules in the signal gate construct(4)3x(5). Figure 5 shows an example of an alternative strategy for an alternative mechanism to detect single-stranded DNA or RNA without an intermediate reporter. The detection gate, a partially double-stranded construct (1) (2), consists of multiple signal oligonucleotides b, c, d, e (1) and a substrate strand (2) containing a'+b'~e' domains complementary to conserved motifs in the nucleotide sequence of interest, where a', the invader strand (3), is a stepping-stone sequence that initiates binding and displacement. Sequence a of the invader strand binds to the a' complementary strand in the detection substrate strand (2). If an additional base matches b', the invader strand (3) also displaces the signal nucleotide (1). The sequence a'+b' is paramount for the specificity of the interaction. Thus, domain b' is longer than c', d' and e'. Signal oligonucleotides with appropriate labels (x in circle) are detected on the chip surface. Example 6 - Analysis of products obtained from analysis of nucleic acids by strand displacement The nucleic acid fragments obtained by the process described in Example 5 were analyzed by gel electrophoresis (see Figures 2A and 2B). The signal oligonucleotide obtained as a result of the strand displacement reaction described herein is seen at 10 bp. Figure 2B shows the gel after a longer exposure time (4000 ms) and clearly shows the presence of the signal oligonucleotide at 8. Figure 2 - Strand displacement reaction yields expected bands. Figure 2A shows each component of the strand displacement reaction and the bands expected to be visualized on a polyacrylamide gel. In Figure 2B1, lanes 2-5 show the single-stranded components Invader, detection substrate, reporter-3, and signal substrate-3. Lanes 6, 7, and 9 show the double-stranded constructs detection gate-3, signal gate-3, and signal waste-3. For the strand displacement reaction product shown in lane 8, Invader, detection gate-3, and signal gate-3 were mixed in equimolar concentrations, incubated at room temperature for 40 min, and then separated on a gel. The reaction yields a detection waste-3 band, and a signal waste-3 band. Additional bands are the result of incomplete strand displacement and represent remnants of the detection gate-3 input. The combination of detection gate-3 and signal gate-3 releases three signal oligonucleotides for each Invader strand. The signal oligonucleotide bands are only visualized at longer exposure times. As shown in Figure 2B2, the overexposed area of the marker is shown in red by the oval area beside the number 10. TIFF2024541674000003.tif237170Strand displacement reactions using three different amounts of signal oligonucleotide were performed and the products were separated by gel electrophoresis (see FIG. 3). As shown here, the process and apparatus disclosed herein can be modified so that each detected invader sequence generates one, two or three oligonucleotides that are then detected. Separation of the fragments by gel electrophoresis shows that increasing the stoichiometric amount of signal oligonucleotide predictably increases the oligonucleotides detected. Figure 3 - Strand displacement reactions yield stoichiometric amounts of signal oligonucleotides. Table A above (combined with Figure 3A) shows samples separated on a TBE buffer polyacrylamide gel (three strand displacement reactions with increasing amounts of signal molecules, the corresponding amounts of pure signal molecules for comparison, and the bands expected to be visualized on the gel). In Figure 3 Error! Reference source not found. B1, lanes 10-12 show the products of displacement reactions 1-3. Lanes 13-15 show the corresponding amounts of signal oligonucleotides. For the strand displacement reaction products shown in lane 8 Invader, detection gate-3 and signal gate-3 were mixed in equimolar concentrations, incubated at room temperature for 40 minutes, and then separated on a gel. This reaction yields a detection waste-3 band, a signal waste-3 band. The additional bands are the result of incomplete strand displacement leaving double-stranded detection gates. The combination of detection gate-3 and signal gate-3 releases three signal oligonucleotides for each Invader strand. As in Figure 3B2, the signal oligonucleotide bands are only visualized at longer exposure times. C shows quantification and relative levels of band brightness compared to 12 pmoles of pure signal oligonucleotide. In reactions 1, 2 and 3, 12 pmoles of reactant can release up to 12, 24 and 36 pmoles of signal oligonucleotide, respectively. Quantification in C shows an increase in signal (S) released from reaction (Rx) 2 to 3 (reaction 1 cannot be analyzed due to interference by fluorescent tag compounds in a similar size range). The overexposed area is shown by a red oval in the image next to number 10 in B2. D is an example of a signal oligonucleotide band used to create a standard curve to calculate the relative concentration of the signal from the gel brightness. Example 8. Detection of ions and DNA on gFET Figure 9 - Detection of ions and DNA on gFET. A: Different concentrations of NaCl solutions (orange arrows) were pipetted onto the graphene sensing area of a gFET, with rinsing with water in between (light blue arrows). Measurements of 0.5M (orange arrows 1-4) and 0.01M NaCl (orange arrows 5-8) were performed in quadruplicate. B: Salmon sperm genomic DNA was diluted in water and transferred to the chip surface in the following order: 0.0001mg / ml, 0.01mg / ml, and 1mg / ml (indicated by orange arrows). The chip was rinsed with water between DNA additions (light blue arrows). C: The chip was then exposed to different concentrations of ssDNA in water in the following order: 1uM, 10uM, 1uM, and 100uM ssDNA (indicated by orange arrows). Between each new DNA concentration, the sensing surface was rinsed with water (light blue arrows). All measured current values for I_sd are plotted in blue, while the average of the last 20 values (equal to one oscillation cycle of V_sd) is shown in orange.
Claims
1. 1. A method for producing one or more electronically readable single stranded nucleic acid sequences, comprising: 1) i) a partially double-stranded detection gate nucleic acid construct (DG), a. a single-stranded detector substrate nucleic acid sequence (DSSS) having a partial region complementary to a partial region of a reporter nucleic acid sequence (RSS) and a stepping-stone sequence (THS) region that is non-complementary to the RSS but partially complementary to a partial sequence of a single-stranded invader nucleic acid sequence (ISS); b. a single-stranded RSS having a region complementary to a portion of the DSSS and a region complementary to one or more electronically readable regions of the signal substrate strand (SSS) but not complementary to the RSS, DSSS, or ISS; A partially double-stranded detection gate nucleic acid construct (DG) comprising: ii) a single stranded invader nucleic acid sequence (ISS) having a region complementary to the THS of the DSSS; iii) a partial double-stranded signal gate construct (SG), a. an SSS that is the complement of the RSS and also contains a toehold sequence (THS) that is complementary to the RSS; b. a plurality of electronically readable signal oligonucleotides (SO) that are complementary to a portion of the SSS but not the THS of the SSS; A partial double-stranded signal gate construct (SG) comprising: selecting 2) reacting the DG with the ISS in a manner and under conditions such that the THS region on the DG initiates binding of the ISS resulting in displacement of the RSS, wherein the RSS further binds to the THS of the SG and releases said one or more electronically readable single stranded SO sequences; The method comprising:
2. 1. A method for producing one or more electronically readable single stranded nucleic acid sequences, comprising: 1) selecting a partially double-stranded detection gate nucleic acid sequence (DG) comprising a detection substrate strand (DS) and one or more signal oligonucleotide (SO) strands comprising a pre-electronically readable sequence, wherein the DS and SO have partial complementarity, and the DG also has a toehold sequence region (THS) and a single-stranded invader nucleic acid sequence (ISS) having a region complementary to the THS and SO regions; 2) reacting the DG with the ISS in such a manner and under such conditions that the THS region on the DG initiates binding with the ISS and displaces one or more electronically readable single-stranded SO from the pre-electronically readable region, where the one or more electronically readable single-stranded nucleic acid sequences are the same or different; The method comprising:
3. 3) electronically detecting one or more electronically readable single-stranded nucleic acid sequences on the graphene surface of the gFET.
4. The method according to any one of claims 1 to 3, wherein the single-stranded invader nucleic acid sequence is single-stranded RNA or single-stranded DNA.
5. The method according to any one of claims 1 to 3, wherein the single-stranded invader nucleic acid is messenger RNA (mRNA) or microRNA (miRNA).
6. The method according to any one of claims 1 to 5, wherein the single-stranded invader nucleic acid sequence may be a naturally occurring nucleic acid sequence.
7. The method according to any one of claims 1 to 6, wherein the invader nucleic acid sequence is of viral, bacterial, plant or microbial origin.
8. The method according to any one of claims 1 to 7, wherein the single-stranded invader nucleic acid sequence is a bridged nucleic acid or a peptide nucleic acid.
9. The method of any one of claims 1 to 8, wherein the single-stranded invader nucleic acid sequence comprises one or more inosine nucleosides.
10. The method according to any one of claims 1 to 8, wherein the single-stranded invader nucleic acid sequence is in the form of an aptamer.
11. The method of any one of claims 1 to 10, wherein the displacement of the electronically readable single-stranded nucleic acid sequence is the result of a toehold strand displacement mediated by a single-stranded invader nucleic acid sequence.
12. The method according to any one of claims 1 to 11, wherein the method comprises the further step of analysing single stranded nucleic acid of a PCR reaction or other polymerase mediated reaction such as sequencing by synthesis.
13. A single stranded invader nucleic acid sequence of about 1 x 10 -6 M ~ approx. 1x10 -18 The method of any one of claims 1 to 12, wherein the compound is present in a concentration of M.
14. The method according to any one of claims 1 to 13, wherein the single-stranded invader nucleic acid replaces one single-stranded signal oligonucleotide sequence.
15. The method according to any one of claims 1 to 12, wherein a single-stranded invader nucleic acid replaces a plurality of single-stranded signal oligonucleotide sequences.
16. The method of any one of claims 1 to 12, wherein the single-stranded invader nucleic acid sequence replaces 1 to 10 single-stranded signal oligonucleotide nucleic acid sequences.
17. A biosensor device comprising a graphene surface, the surface configured to detect a change in charge associated with the method of any one of claims 1 to 16.
18. 20. The biosensor device of claim 17, wherein the biosensor device comprises one or more graphene layers.
